Clinical trial
A Phase 1 Pilot Safety and Feasibility Study of Muscle Progenitor Cell (MPC) Therapy for Urinary Incontinence
NCT01953315 is registered in ClinicalTrials.gov with Wake Forest University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Pilot Safety and Feasibility Study of Muscle Progenitor Cell (MPC) Therapy for Urinary Incontinence
- Lead sponsor
- Wake Forest University
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 31, 2014
- Completion date
- January 31, 2018
- Enrollment
- 10 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.